Drug intelligence / Profile preview

oleoyl-N-hydroxylamide

Development stage
Preclinical
Modality
Small Molecules
Administration
Inhalation, Intravenous, Parenteral
01

Overview

OA-Hy (oleoyl-N-hydroxylamide) is a synthetic small molecule inhibitor of matrix metalloproteinases (MMPs), specifically targeting MMP-2 and MMP-9. It is a hydroxamic acid derivative of oleic acid. The hydroxamate group acts as a zinc-binding moiety that coordinates with the catalytic zinc ion in the active site of the MMP enzymes, thereby blocking their proteolytic activity. OA-Hy is primarily used as a research tool to investigate the role of MMPs in physiological and pathological processes, including extracellular matrix remodeling, angiogenesis, and tumor metastasis. In the context of oncology research, it has been employed to study the mechanisms of cancer cell migration and invasion, such as in endometrial cancer models where it inhibits kisspeptin-induced cell motility.

Other names
cis-9-octadecenoyl-N-hydroxylamidecis9-octadecenoyl-N-hydroxylamidecis 9-octadecenoyl-N-hydroxylamideN-hydroxy-9Z-octadecenamideN-hydroxy9Z-octadecenamideN-hydroxy 9Z-octadecenamideoleoylhydroxamic acid
02

Targets

MMP9 (Matrix metalloproteinase-9)MMP2 (Matrix metalloproteinase-2)

Beyond the preview

Go deeper on oleoyl-N-hydroxylamide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on oleoyl-N-hydroxylamide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call